Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
There has been a rapid grown in the field of tumor immunobiology in recent years as a result of recent successes in cancer
immunotherapies and it is becoming clear that immune cells play many sometimes conflicting roles in the tumor microenvironment.
However, obtaining phenotypic information about the various immune cells that play these roles in and around the tumor has been
a challenge. Existing methods can either deliver phenotypic information on homogenous samples (e.g., flow cytometry or PCR) or
morphologic information on single immunomarkers (standard IHC). We present here a methodology for delivering quantitative
per-cell marker expression and phenotyping, analogous to that obtained from flow cytometry but from cells imaged in situ in FFPE
tissue sections. This methodology combines the sequential multi-marker labeling of up to 6 antigens using antibodies all of the
same species in a single section; automated multispectral imaging (MSI) to remove the typically problematic FFPE tissue auto
fluorescence and correct cross-talk between fluorescent channels and an automated image analysis that can quantitate the per-cell
marker expression, determine the cellular phenotype, count these cells separately in the tumor compartment and in the stroma and
provide high-resolution images of their distributions. We present here several examples of this new methodology in breast, lung and
head and neck cancers. Each application example will show 6-plex multiplexed staining, per-cell quantitation of each marker and
multi-marker cellular phenotyping from multispectral images of standard clinical biopsy sections as well as methods to explore the
spatial distributions of the phenotyped cells in and around the tumor.